Everest Organics has obtained Korea Drug Master File (KDMF) approval for its Rabeprazole Sodium API in the Month of February 2025. The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stomach acid production, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, as it acts as a proton pump inhibitor (PPI) by significantly reducing the amount of acid produced in the stomach; essentially helping to heal ulcers and alleviate symptoms like heartburn and acid reflux. The company is now able to export its Rabeprazole Sodium API to the South Korean market.
Everest Organics carry the business of manufacturing of bulk drugs viz. Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Benzimadizole, etc., having its factory at Sadasivpet Medak District Hyderabad.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1642.80 |
| Dr. Reddys Lab | 1206.10 |
| Cipla | 1205.40 |
| Zydus Lifesciences | 904.70 |
| Lupin | 2310.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: